Elderly patients with dementia-related psychosis treated with anti-psychotic drugs are at an increased risk of death. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. Haloperidol Decanoate (Seredol Deca) is not approved for the treatment of patients with dementia-related psychosis.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
